Barclays
BIOA.WS

Barclays’s BioAmber Inc. BIOA.WS Stock Holding History

Barclays’s Portfolio BIOA.WS Stock Details BIOA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-47
Closed – – 7019
2016
Q1 		$0 Sell
47
-210
-82% -$314 ﹤0.01% 6901
2015
Q4 		$0 Buy
257
+195
+315% +$338 ﹤0.01% 7314
2015
Q3 		$0 Buy
+62
New +$117 ﹤0.01% 7482
2015
Q2 		– Sell
-309
Closed – – 7533
2015
Q1 		$0 Sell
309
-1,157
-79% -$1.91K ﹤0.01% 7604
2014
Q4 		$1K Buy
1,466
+1,253
+588% +$2.52K ﹤0.01% 7217
2014
Q3 		$0 Buy
+213
New +$555 ﹤0.01% 8113
2014
Q2 		– Sell
-68
Closed – – 8122
2014
Q1 		$0 Buy
68
+50
+278% +$117 ﹤0.01% 8012
2013
Q4 		$0 Sell
18
-1
-5% -$1 ﹤0.01% 8005
2013
Q3 		$0 Sell
19
-1,108
-98% -$828 ﹤0.01% 7978
2013
Q2 		$1K Buy
+1,127
New +$715 ﹤0.01% 7649

Other funds holding BIOA.WS

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Barclays's BIOA.WS Position: Q2 2016 in Review

Barclays sold out of BioAmber Inc. (BIOA.WS) in Q2 2016, closing a stake of 47 shares.

Barclays first reported a position in BIOA.WS in Q2 2013 and held it in 10 quarters. The position peaked at $1K in Q4 2014. 10 funds tracked by Wall St. Rank hold BIOA.WS as of Q2 2016.

  • Barclays reported no remaining BioAmber Inc. position as of Q2 2016 after selling out during the quarter.
  • Barclays sold 47 BioAmber Inc. shares in Q2 2016.
  • Barclays first reported a position in BioAmber Inc. in Q2 2013 and held it in 10 quarters.
  • Barclays's BioAmber Inc. position peaked at $1K in Q4 2014.
  • 10 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2016.

Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.